(Kansas City, Missouri) August 16, 2010 - SCD Probiotics, a Kansas City-based manufacturer of probiotic products and technology, announced today the completion of a $2 million dollar Series B equity financing. The Company intends to use the funds to increase their sales and marketing capacity associated with the global rise in demand for probiotic technology, and to further the research and development projects necessary to stay on the leading edge of microbial technology.
Headquartered in Kansas City, Missouri, SCD Probiotics is a life science company focused on the production of beneficial microorganisms that provide sustainable solutions to a variety of consumer, commercial and industrial challenges. Located in the heart of the Animal Health Corridor*, SCD Probiotics is currently developing a line of companion animal products that help improve the digestive health of pets as well as eliminate odors caused by household dogs and cats. Industrial product offerings in SCD’s animal health sector include products that control odor and pathogens in livestock operations.
SCD Probiotics currently employs 15 staff, three of whom hold PhD’s in life science disciplines.
“We are pleased with the recent equity financing as it will position the company to take advantage of the tremendous opportunities that exist in the rapidly expanding probiotic marketplace. SCD’s commitment to R&D and quality manufacturing has given it a foothold in the industry; with this infusion of capital, they are poised for significant sales growth,” says Ed Stevens,
Chief Executive Officer, Pulse NeedleFree Systems and SCD Probiotics board member.
Based in Kansas City, Missouri, USA, SCD Probiotics harnesses nature’s ability to restore personal health and the environment through the development of exclusive probiotic technology. SCD Probiotics Technology utilizes beneficial microorganisms (good bacteria) to repopulate toxic environments with healthy microbes in a variety of industries, including agriculture, animal health, aquaculture, home and garden, human health and environmental applications.
*The Animal Health Corridor expands from Manhattan, Kansas to Columbia, Missouri. Flanked by nationally respected universities, the companies concentrated in this area account for nearly 32% of total sales in the $19 billion global animal health market.